Correlation Between Puma Biotechnology and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Emergent Biosolutions, you can compare the effects of market volatilities on Puma Biotechnology and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Emergent Biosolutions.
Diversification Opportunities for Puma Biotechnology and Emergent Biosolutions
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Puma and Emergent is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Emergent Biosolutions
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 103.44 times less return on investment than Emergent Biosolutions. But when comparing it to its historical volatility, Puma Biotechnology is 2.05 times less risky than Emergent Biosolutions. It trades about 0.0 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 210.00 in Emergent Biosolutions on September 15, 2024 and sell it today you would earn a total of 659.00 from holding Emergent Biosolutions or generate 313.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Emergent Biosolutions
Performance |
| Timeline |
| Puma Biotechnology |
| Emergent Biosolutions |
Puma Biotechnology and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Emergent Biosolutions
The main advantage of trading using opposite Puma Biotechnology and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Emergent Biosolutions vs. Puma Biotechnology | Emergent Biosolutions vs. Iovance Biotherapeutics | Emergent Biosolutions vs. Day One Biopharmaceuticals | Emergent Biosolutions vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |